Company page

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc, trading under the ticker AUPH, is a public company based in the United States with a market capitalization of approximately $1.97 billion. The company focuses on developing innovative therapies for kidney diseases. Aurinia is committed to advancing its research and product pipeline to address unmet medical needs in this area.